Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179812 | SCV000232120 | benign | not specified | 2015-05-01 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514245 | SCV000610007 | likely benign | not provided | 2017-06-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000537794 | SCV000639587 | benign | Spondyloenchondrodysplasia with immune dysregulation | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Institute for Genomic Medicine |
RCV000179812 | SCV000864307 | benign | not specified | 2017-03-17 | criteria provided, single submitter | clinical testing | BS1, BS2, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
Center for Genomics, |
RCV000537794 | SCV000898501 | uncertain significance | Spondyloenchondrodysplasia with immune dysregulation | 2021-11-23 | criteria provided, single submitter | clinical testing | ACP5 NM_001111035.2 exon 7 p.Arg272Cys (c.814C>T): This variant has not been reported in the literature but is present in 0.4% (595/126376) of European alleles, including 3 homozygotes, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/19-11685989-G-A). This variant is present in ClinVar, with several labs classifying this variant as likely benign or benign (Variation ID:198455). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV000514245 | SCV001246014 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | ACP5: BP4, BS2 |
Gene |
RCV000514245 | SCV001993674 | uncertain significance | not provided | 2022-04-04 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Prevention |
RCV003955090 | SCV004769636 | likely benign | ACP5-related disorder | 2022-05-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000514245 | SCV001799199 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000514245 | SCV001931762 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514245 | SCV001963823 | likely benign | not provided | no assertion criteria provided | clinical testing |